Accessibility Menu
 
Htg Molecular Diagnostics logo

Htg Molecular Diagnostics

(OTC) HTGMQ

Current Price$0.00
Market Cap$200
Since IPO (2015)-100%
5 Year-100%
1 Year+0%
1 Month+0%

Htg Molecular Diagnostics Financials at a Glance

Market Cap

$200

Revenue (TTM)

$6.21M

Net Income (TTM)

$20.15M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

67.57 (High)

Price

$0.00

Volume

2

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

HTGMQ News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Htg Molecular Diagnostics

Industry

Health Care Technology

Employees

53

CEO

John L. Lubniewski

Headquarters

Tucson, AZ 85706, US

HTGMQ Financials

Key Financial Metrics (TTM)

Gross Margin

28%

Operating Margin

-3%

Net Income Margin

-3%

Return on Equity

0%

Return on Capital

-2%

Return on Assets

-1%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$200.00

Shares Outstanding

2.21M

Volume

2

Avg. Volume

271.825

Financials (TTM)

Gross Profit

$1.79M

Operating Income

$20.83M

EBITDA

$20.14M

Operating Cash Flow

$18.41M

Capital Expenditure

$23.04K

Free Cash Flow

$18.43M

Cash & ST Invst.

$12.21M

Total Debt

$8.35M

Htg Molecular Diagnostics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2023YOY CHG

Revenue

$1.03M

-12.8%

Gross Profit

$117.10K

-135.5%

Gross Margin

-11.34%

N/A

Market Cap

$200.00

N/A

Market Cap/Employee

$3.77

N/A

Employees

53

N/A

Net Income

$5.05M

+22.2%

EBITDA

$4.83M

+20.4%

Quarterly Fundamentals

Name
Q1 2023YOY CHG

Net Cash

$2.58M

-78.6%

Accounts Receivable

$1.13M

+51.1%

Inventory

$654.92K

-67.6%

Long Term Debt

$423.24K

-89.5%

Short Term Debt

$3.56M

-34.4%

Return on Assets

-1.21%

N/A

Return on Invested Capital

-2.19%

N/A

Free Cash Flow

$4.37M

+26.5%

Operating Cash Flow

$4.36M

+26.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MDVLQMedAvail Holdings, Inc.
$0.00+0.00%
HLTHQCue Health Inc.
$0.00+0.00%
NEXINexImmune, Inc.
$0.00+0.00%
BIOCQBiocept, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.07+0.05%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.70+0.01%
SOFISoFi Technologies
$16.43+0.02%
SOUNSoundHound AI
$9.56+0.20%

Questions About HTGMQ

What is the current price of Htg Molecular Diagnostics?

Htg Molecular Diagnostics is trading at $0.00 per share.

What is the 52-week range for Htg Molecular Diagnostics?

Over the past 52 weeks, Htg Molecular Diagnostics has traded between $0.00 and $0.00.

How much debt does Htg Molecular Diagnostics have?

As of the most recent reporting period, Htg Molecular Diagnostics reported total debt of $8.80M.

How much cash does Htg Molecular Diagnostics have on hand?

Htg Molecular Diagnostics reported $12.21M in cash and cash equivalents in its most recent financial results.

What is Htg Molecular Diagnostics’s dividend yield?

Htg Molecular Diagnostics does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.